FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CDER Making Stealth Comparative Effectiveness Decisions: Pendergast.

[ Price : $8.95]

Former FDA deputy commissioner Mary Pendergast warns that CDER is making stealth comparative effectiveness decisions on standard N...

FDA Plans Spring 2010 Advisory Meeting on Opioid REMS

[ Price : $8.95]

FDA says it will consider information presented by an industry working group on opioid REMS and take its recommendations to an adv...

FDA Wants More Aveed Data

[ Price : $8.95]

An FDA complete response letter on Endos Aveed testosterone injection asks for more adverse event information and a revised REMS.

Public Citizen Again Asks for Meridia Ban

[ Price : $8.95]

Public Citizen again calls on FDA to immediately pull Abbotts Meridia from the U.S. market.

Mesantoin Not Withdrawn for S&E

[ Price : $8.95]

Federal Register Notice: FDA determines that Mesantoin (mephenytoin) tablets, 100 mg, were not withdrawn for reasons of safety or ...

Immunogenicity Testing Assay Development Guidance Out

[ Price : $8.95]

FDA issues a draft guidance with recommendations to facilitate developing immune assays for assessing therapeutic protein immunoge...

FDA Reminder on Valproate Concerns

[ Price : $8.95]

FDA posts information for healthcare professionals on birth defects associated with exposure to valproate sodium during pregnancy.

WLF Backs Allergan Off-label Suit

[ Price : $8.95]

Washington Legal Foundation and three patient groups say they support Allergans challenge to FDA regulations preventing it from sh...

FDA, Genzyme Agree to Lumizyme Manufacturing Change

[ Price : $8.95]

Genzyme says it will ask FDA to approve manufacturing Lumizyne at a larger bioreactor scale to avoid problems at its Allston, MA, ...

Abilify Discmelt Not Withdrawn for S&E

[ Price : $8.95]

Federal Register Notice: FDA determines that Abilify Discmelt orally disintegrating tablets, 20 and 30 mg were not withdrawn from ...